EUVIMEDEUVIMED entdecken
Crossref

Transcytosis-Enabled Paclitaxel Prodrugs for Potentiated Chemotherapy

Xiujuan Xiang, Hui Wen iD, Tao Zhang, Chong Ma, Biyou Zhang, Qing Pei, Zhigang Xie iD

ACS Nano · 2025

DOI: 10.1021/acsnano.5c06886 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2025. Verfasst von Xiujuan Xiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Polymer Science and Technology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 13002…. Hauptthemen laut MEDLINE: Prodrugs, Paclitaxel, Transcytosis, Antineoplastic Agents, Phytogenic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Jilin Provincial Health Research Talent Special Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsPaclitaxelTranscytosisAntineoplastic Agents, PhytogenicAntineoplastic AgentsAnimalsHumansMiceNanoparticlesCell Line, TumorMice, Inbred BALB CCell SurvivalDrug Screening Assays, AntitumorPolyethylene Glycols

Stichwörter der Autor:innen

N-oxidenanomedicinepaclitaxelprodrugtranscytosis

Substanzen

ProdrugsPaclitaxelAntineoplastic Agents, PhytogenicAntineoplastic AgentsPolyethylene Glycols

Autor:innen und Institutionen

  • State Key Laboratory of Polymer Science and Technology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, P. R. China.
  • School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, Anhui 230026, P. R. China.
  • China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P. R. China.

ORCID-Profile: Hui Wen, Zhigang Xie

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Jilin Provincial Health Research Talent Special Project

Zitieren

APA

Xiang, X., Wen, H., Zhang, T., Ma, C., Zhang, B., Pei, Q., & Xie, Z. (2025). Transcytosis-Enabled Paclitaxel Prodrugs for Potentiated Chemotherapy. ACS Nano. https://doi.org/10.1021/acsnano.5c06886

Vancouver

Xiang X, Wen H, Zhang T, Ma C, Zhang B, Pei Q, et al. Transcytosis-Enabled Paclitaxel Prodrugs for Potentiated Chemotherapy. ACS Nano. 2025. doi:10.1021/acsnano.5c06886

BibTeX
@article{Xiang2025,
  author = {Xiang, Xiujuan and Wen, Hui and Zhang, Tao and Ma, Chong and Zhang, Biyou and Pei, Qing and Xie, Zhigang},
  title = {Transcytosis-Enabled Paclitaxel Prodrugs for Potentiated Chemotherapy},
  journal = {ACS Nano},
  year = {2025},
  doi = {10.1021/acsnano.5c06886}
}
Kostenlos starten →